Biomarker risk assessment model identified high-risk patients with cancer who benefit from thromboprophylaxis

Sander Veldhuyzen van Zanten,Bruce Ritchie

ANNALS OF INTERNAL MEDICINE（2024）

引用 0|浏览0

暂无评分

摘要

Source Citation Alexander M, Harris S, Underhill C, et al. Risk-directed ambulatory thromboprophylaxis in lung and gastrointestinal cancers: the TARGET-TP randomized clinical trial. JAMA Oncol. 2023;9:1536-1545. 37733336 Clinical Impact Ratings GIM/FP/GP: Hematology:

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要